P-body 2026-11-05
A P-body, or processing body, is a cytoplasmic assembly of RNA and proteins associated with nontranslating messenger RNA and factors involved in decapping and RNA decay. Its molecular composition and exchange with the surrounding cytoplasm distinguish it from a membrane-bounded container or a fixed pile of cellular waste.
The 2003 yeast study localized decay-related factors and RNA degradation intermediates to these foci, and altered RNA-turnover steps to test their functional relationship to processing.[ref] This connects cellular location to a biochemical pathway; it does not establish that every RNA must pass through a visible focus to be degraded.
A 2005 study tested P-body assembly more directly. RNA digestion disrupted enriched P-body preparations. In cells, inhibition of translation initiation increased P-bodies, whereas inhibition of elongation trapped messages in polysomes and promoted P-body dissociation.[ref] The opposite outcomes show why saying only that translation was inhibited leaves an important mechanistic distinction unresolved.
An original pool model explains why a larger focus need not mean faster degradation. Let count RNA molecules in a processing pool, with entry rate and first-order removal rate :
With stipulated molecules per minute and , the steady state contains 20 molecules. Lowering to increases that pool to 60, while the steady removal flux remains molecules per minute. Even if removal represents degradation, pool size and throughput are different measurements. This is a teaching model, not measured P-body kinetics; actual pools can also exchange RNA through other routes.
Fluorescence microscopy measures labeled components under a stated imaging procedure. Interpreting intensity as RNA number needs an additional response model, and counting spots need not measure either molecular number or reaction flux. Localization, composition, assembly and turnover consequently provide complementary tests of what a P-body is doing.
Roy Parker 2026-11-05
Roy Parker is a molecular biologist studying how cells produce, translate and degrade messenger RNA. His University of Colorado Boulder profile describes this research program, and his institutional curriculum vitae records a genetics doctorate from the University of California, San Francisco in 1985.[ref]
His early work helped establish a sequence-recognition role for U2 small nuclear RNA. In a 1987 collaborative study, compensating changes in U2 suppressed corresponding changes in the yeast intron branch region. The matching suppression connected RNA sequence to base pairing in RNA splicing, rather than merely associating U2 with the machinery.[ref]
A later study with Ujwal Sheth connected RNA decay to cellular location. Functional fusions to green fluorescent protein placed several decapping factors in discrete cytoplasmic foci, termed P-bodies. Perturbing steps of the decay pathway changed those foci, and RNA decay intermediates also localized there.[ref]
The combination of imaging and perturbation is scientifically important. A fluorescent spot alone shows where a marked component accumulates; it does not establish what reaction happens there. Comparing locations with the consequences of changing particular processing steps tests a mechanistic explanation. Nor does an accumulation of decay intermediates automatically mean that decay has become faster: material can accumulate when an exit step is blocked. This connects the chemistry of messenger RNA processing to the organization and dynamics of the cytoplasm.
Figure 1.
Roy Parker, portrait on his University of Colorado Boulder BioFrontiers profile
.
Ujwal Sheth 2026-11-05
Ujwal Sheth is a molecular biologist associated with experimental studies of messenger RNA localization and turnover. A 2003 paper with Roy Parker, listing a University of Arizona research affiliation, investigated the relationship between RNA decay and discrete cytoplasmic structures named P-bodies.[ref]
The study combined localization with functional perturbations. Factors involved in decapping accumulated in cytoplasmic foci, and RNA degradation intermediates localized there. Interfering with different steps of RNA turnover changed the abundance of the foci. These comparisons helped distinguish a compartment associated with processing from a fluorescent aggregation seen without a functional test.[ref]
Sheth also coauthored a 2005 study linking P-body assembly to nontranslating RNA. Its experiments connected assembly to RNA integrity and showed contrasting responses to inhibition of translation initiation and elongation.[ref] The work made RNA's participation a testable part of the explanation, beyond treating the visible focus as a container for proteins.
The broader scientific lesson is to connect three kinds of evidence: where molecules localize, what happens when a pathway changes, and whether the proposed components are needed for assembly. A change in spot number alone does not identify the direction or rate of RNA processing. These questions connect cell organization with the lifetime and use of a genetic message.
A captioned laboratory photograph of Sheth beside Roy Parker appears on PDF page 9 of HHMI Bulletin September 2003 by Howard Hughes Medical Institute.